Aprea Therapeutics, Inc. Shares Outstanding (Cover Page)
Aprea Therapeutics, Inc. (APRE) had Shares Outstanding (Cover Page) of 12.59 million shares as of 2026-08-12, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-12: Entity Common Stock, Shares Outstanding 12.59M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 12.38M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 11.45M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 6.31M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 12.59M shares 10-Q · filed 2026-08-12 |
| 2026-05-13 | 12.38M shares 10-Q · filed 2026-05-13 |
| 2026-03-16 | 11.45M shares 10-K · filed 2026-03-16 |
| 2025-11-11 | 6.31M shares 10-Q · filed 2025-11-12 |
| 2025-08-11 | 5.83M shares 10-Q · filed 2025-08-12 |
| 2025-05-13 | 5.53M shares 10-Q · filed 2025-05-14 |
| 2025-03-25 | 5.49M shares 10-K · filed 2025-03-25 |
| 2024-11-07 | 5.43M shares 10-Q · filed 2024-11-07 |
| 2024-08-09 | 5.43M shares 10-Q · filed 2024-08-12 |
| 2024-05-14 | 5.43M shares 10-Q · filed 2024-05-14 |
| 2024-03-26 | 5.43M shares 10-K · filed 2024-03-26 |
| 2023-11-09 | 3.74M shares 10-Q · filed 2023-11-09 |
| 2023-08-10 | 3.74M shares 10-Q · filed 2023-08-10 |
| 2023-05-15 | 3.73M shares 10-Q · filed 2023-05-15 |
| 2023-04-27 | 3.73M shares 10-K/A · filed 2023-04-28 |
| 2023-03-28 | 3.73M shares 10-K · filed 2023-03-30 |
| 2022-11-09 | 53.00M shares 10-Q · filed 2022-11-09 |
| 2022-08-10 | 23.40M shares 10-Q · filed 2022-08-12 |
| 2022-05-13 | 21.97M shares 10-Q · filed 2022-05-16 |
| 2022-03-14 | 21.97M shares 10-K/A · filed 2022-05-02 |
| 2021-11-08 | 21.47M shares 10-Q · filed 2021-11-08 |
| 2021-08-12 | 21.19M shares 10-Q · filed 2021-08-12 |
| 2021-05-06 | 21.19M shares 10-Q · filed 2021-05-06 |
| 2021-03-16 | 21.19M shares 10-K · filed 2021-03-16 |
| 2020-11-06 | 21.19M shares 10-Q · filed 2020-11-06 |
| 2020-08-11 | 21.19M shares 10-Q · filed 2020-08-11 |
| 2020-05-15 | 21.05M shares 10-Q · filed 2020-05-15 |
| 2020-03-27 | 21.05M shares 10-K · filed 2020-03-27 |
| 2019-11-13 | 20.99M shares 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |